Atalan Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Willis Towers Watson
WTW
|
+$53.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$50.6M |
| 3 |
Marvell Technology
MRVL
|
+$14.5M |
| 4 |
US Foods
USFD
|
+$4.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$60.1M |
| 2 |
Palo Alto Networks
PANW
|
+$37.9M |
| 3 |
TransDigm Group
TDG
|
+$28.1M |
| 4 |
SGI
Somnigroup International
SGI
|
+$25.3M |
| 5 |
S&P Global
SPGI
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.76% |
| 2 | Healthcare | 20.05% |
| 3 | Industrials | 19.96% |
| 4 | Technology | 19.78% |
| 5 | Consumer Staples | 14.04% |
Similar funds
Atalan Capital Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Atalan Capital Partners held 15 positions worth $1.07B, down 16% from $1.27B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Atalan Capital Partners withdrew a net $99.1M in Q3 2023, closing 4 positions and reducing 5 holdings. Its most notable exit was Somnigroup International, an estimated $25.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Atalan Capital Partners opened a new position in Willis Towers Watson worth $52.2M.
- Atalan Capital Partners's largest Q3 2023 buy was Willis Towers Watson: 250,000 shares worth $52.2M.
- Atalan Capital Partners added most to Thermo Fisher Scientific in Q3 2023, an estimated $50.6M increase.
- Atalan Capital Partners's biggest Q3 2023 reduction was Visa, cutting an estimated $60.1M.
- Atalan Capital Partners fully exited Somnigroup International in Q3 2023, selling an estimated $25.3M.
- Atalan Capital Partners's ten largest holdings make up 100% of its $1.07B portfolio in Q3 2023.
- Atalan Capital Partners opened 1 new position and closed 4 in Q3 2023.
- Atalan Capital Partners's portfolio value fell 16% quarter-over-quarter to $1.07B.
Based on Atalan Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.